Showing results (411-420 of 733) with videos related to

Sort By:
Pageof 74
Cell Reports|January 16, 2020
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell ResponsesJulianna Blagih, Fabio Zani, Probir Chakravarty, et al.
Communications Biology|January 16, 2026
Long-term exposure to the ethanol-derived metabolite acetaldehyde elevates structural genomic alterations but not base substitutionsRita Lózsa, Bernadett Szikriszt, Eszter Németh, et al.
Pigment Cell & Melanoma Research|November 21, 2017
Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenibMatthew J Wongchenko, Antoni Ribas, Brigitte Dréno, et al.
Frontiers in Oncology|June 26, 2023
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanomaSebastian Bauer, James Larkin, F Stephen Hodi, et al.
Cancers|September 13, 2025
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre StudyUmair Mahmood, Eleni Josephides, Meenali Chitnis, et al.
Breast Cancer Research : BCR|November 21, 2013
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumorsClifford Hudis, Charles Swanton, Yelena Y Janjigian, et al.
Journal of Cell Science|May 13, 2014
Ccdc13 is a novel human centriolar satellite protein required for ciliogenesis and genome stabilityChristopher J Staples, Katie N Myers, Ryan D D Beveridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway TrialFunda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney, et al.
Cancer Discovery|June 29, 2024
The History of Chromosomal Instability in Genome-Doubled TumorsToby M Baker, Siqi Lai, Andrew R Lynch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Pageof 74